The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  CNS drug reviews

• Publication date

  2007-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1527-3458.2007.00024.XPMID 18078428PMCID PMC6494167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The mGluR2/3 agonist LY379268 attenuates context- and discrete cue-induced reinstatement of sucrose seeking but not sucrose self-administration in rats.

  2006influential reference
• The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats

  2006cited by this paper
• Activation of Group II Metabotropic Glutamate Receptors in the Nucleus Accumbens Shell Attenuates Context-Induced Relapse to Heroin Seeking

  2006influential reference
• Effects of the mGluR2/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat.

  2006cited by this paper
• Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG.

  2005cited by this paper
• Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing.

  2005cited by this paper
• Comparison of the effects of diazepam, the CRF1 antagonist CP-154,526 and the group II mGlu receptor agonist LY379268 on stress-evoked extracellular norepinephrine levels.

  2005cited by this paper
• Dopamine is not Required for the Hyperlocomotor Response to NMDA Receptor Antagonists

  2005cited by this paper
• Metabotropic glutamate receptors as novel targets for anxiety and stress disorders

  2005cited by this paper
• The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking

  2005cited by this paper
• Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine‐induced down‐regulation of β‐adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands

  2005cited by this paper
• A Selective Allosteric Potentiator of Metabotropic Glutamate (mGlu) 2 Receptors Has Effects Similar to an Orthosteric mGlu2/3 Receptor Agonist in Mouse Models Predictive of Antipsychotic Activity

  2005cited by this paper
• The preferential mGlu2/3 receptor antagonist, LY341495, reduces the frequency of spike-wave discharges in the WAG/Rij rat model of absence epilepsy.

  2005cited by this paper
• In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands

  2004cited by this paper
• Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell.

  2004cited by this paper
• The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease.

  2004cited by this paper
• Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli

  2004cited by this paper
• Activation of group II mGlu receptors blocks the enhanced drug taking induced by previous exposure to amphetamine

  2004cited by this paper
• Preferential Effects of the Metabotropic Glutamate 2/3 Receptor Agonist LY379268 on Conditioned Reinstatement versus Primary Reinforcement: Comparison between Cocaine and a Potent Conventional Reinforcer

  2004cited by this paper
• A Role of Ventral Tegmental Area Glutamate in Contextual Cue-Induced Relapse to Heroin Seeking

  2004cited by this paper
• The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: possible implications for psychosis.

  2004cited by this paper
• Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice

  2003cited by this paper
• Comparison of the effect of glutamate receptor modulators in the 6 Hz and maximal electroshock seizure models.

  2003cited by this paper
• Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.

  2003cited by this paper
• Group II Metabotropic Glutamate Receptors Regulate the Vulnerability to Hypoxic Brain Damage

  2003cited by this paper
• Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders

  2003cited by this paper
• Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.

  2003cited by this paper
• Endogenous activation of group-II metabotropic glutamate receptors inhibits the hypothalamic-pituitary-adrenocortical axis.

  2003cited by this paper
• Group II mGlu Receptor Activation Suppresses Norepinephrine Release in the Ventral Hippocampus and Locomotor Responses to Acute Ketamine Challenge

  2003cited by this paper
• Toluene-Induced Locomotor Activity is Blocked by 6-Hydroxydopamine Lesions of the Nucleus Accumbens and the mGluR2/3 Agonist LY379268

  2003cited by this paper
• Group II Metabotropic Glutamate Receptor Modulation of DOI-induced c-fos mRNA and Excitatory Responses in the Cerebral Cortex

  2003cited by this paper
• Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice.

  2002cited by this paper
• Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment.

  2002cited by this paper
• Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats.

  2002influential reference
• Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus.

  2002cited by this paper
• Systemic pre‐treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo

  2002cited by this paper
• The Group II Metabotropic Glutamate Receptor Agonist (−)-2-Oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and Clozapine Reverse Phencyclidine-Induced Behaviors in Monoamine-Depleted Rats

  2002cited by this paper
• Direct and indirect modulation of the N-methyl D-aspartate receptor.

  2002cited by this paper
• Diagnosis, prevention and treatment of aspirin-induced asthma and rhinitis.

  2002cited by this paper
• Modulation of stress-induced and stimulated hyperprolactinemia with the group II metabotropic glutamate receptor selective agonist, LY379268.

  2002cited by this paper
• Effects of the mGlu2/3 receptor agonist LY379268 on motor activity in phencyclidine-sensitized rats.

  2002cited by this paper
• Astrocyte mGlu(2/3)-mediated cAMP potentiation is calcium sensitive: studies in murine neuronal and astrocyte cultures.

  2002cited by this paper
• Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease.

  2002cited by this paper
• The mGlu2/3 receptor agonist LY379268 blocks the expression of locomotor sensitization by amphetamine.

  2002cited by this paper
• Selective Blockade of mGlu5 Metabotropic Glutamate Receptors Is Protective against Methamphetamine Neurotoxicity

  2002cited by this paper
• Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system.

  2001cited by this paper
• Anti-epileptic activity of group II metabotropic glutamate receptor agonists (--)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (--)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795).

  2001cited by this paper
• Activity-dependent presynaptic autoinhibition by group II metabotropic glutamate receptors at the perforant path inputs to the dentate gyrus and CA1.

  2001cited by this paper
• Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade.

  2001cited by this paper
• Retracted: Neuroprotection mediated by glial group‐II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol‐3‐kinase pathways

  2001influential reference
• Glutamate uptake.

  2001cited by this paper
• Changes in Rat Serum Corticosterone After Treatment with Metabotropic Glutamate Receptor Agonists or Antagonists

  2001cited by this paper
• Alterations in behaviour and glutamate transmission following presentation of stimuli previously associated with cocaine exposure

  2001cited by this paper
• Glutamate Receptors and Nociception

  2001cited by this paper
• Time-Dependent Reversal of Long-Term Potentiation by Low-Frequency Stimulation at the Hippocampal Mossy Fiber–CA3 Synapses

  2001cited by this paper
• The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing.

  2000influential reference
• The genome as a drug target: sequence specific minor groove binding ligands.

  2000cited by this paper
• l-glutamate as a central neurotransmitter: looking back.

  2000cited by this paper
• Groups II and III metabotropic glutamate receptors differentially modulate brief and prolonged nociception in primate STT cells.

  2000cited by this paper
• Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum.

  2000influential reference
• Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo.

  2000influential reference
• Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine

  2000influential reference
• Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors

  2000influential reference
• The Potent, Selective mGlu2/3 Receptor Agonist LY379268 Increases Extracellular Levels of Dopamine, 3,4‐Dihydroxyphenylacetic Acid, Homovanillic Acid, and 5‐Hydroxyindole‐3‐Acetic Acid in the Medial Prefrontal Cortex of the Freely Moving Rat

  2000influential reference
• Memantine and ACPC affect conditioned place preference induced by cocaine in rats.

  2000cited by this paper
• Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.

  2000cited by this paper
• Metabotropic glutamate receptors: electrophysiological properties and role in plasticity.

  1999cited by this paper
• The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.

  1999cited by this paper
• Group II Selective Metabotropic Glutamate Receptor Agonists and Local Cerebral Glucose use in the Rat

  1999cited by this paper
• Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release.

  1999cited by this paper
• Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.

  1999influential reference
• Neuroprotective Actions of Novel and Potent Ligands of Group I and Group II Metabotropic Glutamate Receptors

  1999cited by this paper
• Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795.

  1999cited by this paper
• Pharmacological agents acting at subtypes of metabotropic glutamate receptors.

  1999cited by this paper
• LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia.

  1999cited by this paper
• Protection of neonatal rat brain from hypoxic-ischemic injury by LY379268, a Group II metabotropic glutamate receptor agonist.

  1999cited by this paper
• Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268

  1999influential reference
• The Neuropsychopharmacology of Phencyclidine: From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia

  1999cited by this paper
• Metabotropic glutamate receptors 2 and 3 expressed by astrocytes in rat ventrobasal thalamus.

  1999cited by this paper
• Selective activation of group II mGluRs with LY354740 does not prevent neuronal excitotoxicity.

  1999cited by this paper
• Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody.

  1998cited by this paper
• Regulation of the glial Na+-dependent glutamate transporters by cyclic AMP analogs and neurons.

  1998cited by this paper
• Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats.

  1998cited by this paper
• Changes in subcellular localization of metabotropic glutamate receptor subtypes during postnatal development of mouse thalamus

  1998cited by this paper
• Neuroprotection by Glial Metabotropic Glutamate Receptors Is Mediated by Transforming Growth Factor-β

  1998cited by this paper
• Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia.

  1998cited by this paper
• AMPA receptors and motivation for drug: effect of the selective antagonist NBQX on behavioural sensitization and on self-administration in mice

  1998cited by this paper
• Pharmacology and functions of metabotropic glutamate receptors.

  1997cited by this paper
• Cloning, distribution and functional expression of the human mGlu6 metabotropic glutamate receptor.

  1997cited by this paper
• The Neuroprotective Activity of Group-II Metabotropic Glutamate Receptors Requires New Protein Synthesis and Involves a Glial–Neuronal Signaling

  1997cited by this paper
• Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

  1997cited by this paper
• Expression of glutamate uptake transporters after dibutyryl cyclic AMP differentiation and traumatic injury in cultured astrocytes.

  1997cited by this paper
• Differential Presynaptic Localization of Metabotropic Glutamate Receptor Subtypes in the Rat Hippocampus

  1997cited by this paper
• Design, Synthesis, and Pharmacological Characterization of (+)-2- Aminobicyclo(3.1.0)hexane-2,6-dicarboxylic Acid (LY354740): A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties.

  1997influential reference
• Use-dependent increases in glutamate concentration activate presynaptic metabotropic glutamate receptors

  1997cited by this paper
• Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties.

  1997influential reference
• mGluR II agonist inhibition of LTP induction, and mGluR II antagonist inhibition of LTD induction, in the dentate gyrus in vitro

  1997cited by this paper
• The contribution of metabotropic glutamate receptors (mGluRs) to formalin‐induced nociception

  1996cited by this paper
• Roles of metabotropic glutamate receptors in glial function and glial‐neuronal communication

  1996cited by this paper
• Modulation of glial cell signaling by adenosine and pharmacological reinforcement

  1996cited by this paper

• Glutamate transmission in the prelimbic cortex and nucleus accumbens shell is involved in ethanol reinforcement and drinking in rats.

  2026influential citation
• Effectiveness of positive allosteric modulators of metabotropic glutamate receptor 2/3 (mGluR2/3) in animal models of schizophrenia

  2025cites this paper
• mGluR2/3 receptor agonist LY379268 alleviates PTSD-like fear memories by downregulating the CaMKII/CREB signaling pathway in the hippocampus and prefrontal cortex.

  2025cites this paper
• Activating Group II Metabotropic Glutamate Receptors in the Basolateral Amygdala Inhibits Increases in Reward Seeking Triggered by Discriminative Stimuli in Rats.

  2025cites this paper
• Glutamate as a Therapeutic Substrate in Migraine

  2025cites this paper
• The Role of Glutamate Receptors in Ischemic Stroke

  2025cites this paper
• Activation of Group II Metabotropic Glutamate Receptors in the Basolateral Amygdala Inhibits Reward Seeking Triggered by Discriminative Stimuli

  2024cites this paper
• Triggered Temptations: A New Procedure to Compare Reward-Seeking Behaviour Induced by Discriminative and Conditioned Stimuli in Rats

  2024cites this paper
• Structural basis of orientated asymmetry in a mGlu heterodimer

  2024cites this paper
• Dusting off old blueprints: Is it time to reconsider metabotropic glutamate receptor 2 for therapeutic drug development?

  2024cites this paper
• Effects of the PAM of mGluR2, JNJ-46356479, on brain apoptotic protein levels in a mouse model of schizophrenia.

  2024cites this paper
• Effects of the mGlu2/3 receptor agonist LY379268 on two models of disturbed auditory evoked brain oscillations in mice

  2023cites this paper
• Metabotropic glutamate group II receptor activation in the ventrolateral dorsal striatum suppresses incentive motivation for cocaine in rats

  2023cites this paper
• Activation of mGlu2/3 receptors in the striatum alleviates L-DOPA-induced dyskinesia and inhibits abnormal postsynaptic molecular expression.

  2023cites this paper
• Clinical investigations of compounds targeting metabotropic glutamate receptors.

  2022cites this paper
• Metabotropic group II glutamate receptors mediate cue-triggered increases in reward-seeking behaviour

  2022cites this paper
• Exploration of group II metabotropic glutamate receptor modulation in mouse models of Rett syndrome and MECP2 Duplication syndrome.

  2022cites this paper
• Deficiency of kynurenine 3-monooxygenase exacerbates impairment of prepulse inhibition induced by phencyclidine.

  2022cites this paper
• Metabotropic glutamate group II receptor activation in the dorsal striatum suppresses the motivation for cocaine in rats

  2022influential citation
• Acute administration of typical and atypical antipsychotics reduces EEG power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in power

  2021cites this paper
• Metabotropic group II glutamate receptors mediate cue-triggered increases in incentive motivation for reward

  2021cites this paper
• Metabotropic Glutamate Receptor 2/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice

  2021cites this paper
• G-Protein-Coupled Receptors and Ischemic Stroke: a Focus on Molecular Function and Therapeutic Potential

  2021cites this paper
• Control of impulsivity by Gi-protein signalling in layer-5 pyramidal neurons of the anterior cingulate cortex

  2021cites this paper
• Metabotropic group II glutamate receptors in the basolateral amygdala mediate cue-triggered increases in incentive motivation

  2021cites this paper
• Development of Clickable Photoaffinity Ligands for Metabotropic Glutamate Receptor 2 Based on Two Positive Allosteric Modulator Chemotypes.

  2020cites this paper
• Metabotropic glutamate 2,3 receptor stimulation desensitizes agonist activation of G‐protein signaling and alters transcription regulators in mesocorticolimbic brain regions

  2020influential citation
• N-Acetylaspartylglutamate (NAAG) Pretreatment Reduces Hypoxic-Ischemic Brain Damage and Oxidative Stress in Neonatal Rats

  2020cites this paper
• Presynaptic Release-regulating Metabotropic Glutamate Receptors: An Update

  2019influential citation
• Amygdala group II mGluRs mediate the inhibitory effects of systemic group II mGluR activation on behavior and spinal neurons in a rat model of arthritis pain.

  2019cites this paper
• LY379268 Does Not Have Long-Term Procognitive Effects nor Attenuate Glutamatergic Signaling in AβPP/PS1 Mice

  2019cites this paper
• Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer’s Disease Progression

  2019cites this paper
• Pretreatment with Group II Metabotropic Glutamate Receptor Agonist LY379268 Protects Neonatal Rat Brains from Oxidative Stress in an Experimental Model of Birth Asphyxia

  2018cites this paper
• The activation of group II metabotropic glutamate receptors protects neonatal rat brains from oxidative stress injury after hypoxia-ischemia

  2018cites this paper
• Schizophrenia-related cognitive dysfunction in the Cyclin-D2 knockout mouse model of ventral hippocampal hyperactivity

  2018cites this paper
• N-acetylaspartylglutamate Inhibits Heroin Self-Administration and Heroin-Seeking Behaviors Induced by Cue or Priming in Rats

  2017cites this paper
• Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder.

  2017cites this paper
• mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia

  2016cites this paper
• Developmental expression of mGlu2 and mGlu3 in the mouse brain.

  2016cites this paper
• Cortical regulation of striatal projection neurons and interneurons in a Parkinson's disease rat model

  2016cites this paper
• New 4-Functionalized Glutamate Analogues Are Selective Agonists at Metabotropic Glutamate Receptor Subtype 2 or Selective Agonists at Metabotropic Glutamate Receptor Group III.

  2016cites this paper
• Pharmacokinetic and pharmacodynamic characterisation of JNJ-40411813, a positive allosteric modulator of mGluR2, in two randomised, double-blind phase-I studies

  2015cites this paper
• To Break or to Brake Neuronal Network Accelerated by Ammonium Ions?

  2015cites this paper
• Activation of mGluR2/3 following stress hormone exposure restores sensitivity to alcohol in rats.

  2015influential citation
• Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813

  2015cites this paper
• Chronic administration of antipsychotics attenuates ongoing and ketamine-induced increases in cortical γ oscillations.

  2014cites this paper
• Stimulating ERK/PI3K/NFκB signaling pathways upon activation of mGluR2/3 restores OGD‐induced impairment in glutamate clearance in astrocytes

  2014cites this paper
• Altered object exploration but not temporal order memory retrieval in an object recognition test following treatment of rats with the group II metabotropic glutamate receptor agonist LY379268.

  2014influential citation
• Oscillations dans la bande de fréquence gamma dans des modèles de rongeurs pour la schizophrénie

  2014cites this paper
• Bioanalysis of (1R,4R,5S,6R)-4-amino-2-oxabicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY379268) in rat plasma using derivatization liquid chromatography/mass spectrometry.

  2014cites this paper
• Gamma frequency oscillations in rodent models for schizophrenia

  2014cites this paper
• Metabotropic Glutamate Receptor 2 Activators

  2014cites this paper
• Chemical biology of mGlu4 receptor activation: dogmas, challenges, strategies and opportunities.

  2014cites this paper
• The effect of ((-)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis.

  2014cites this paper
• Group II metabotropic glutamate receptors modify N-methyl-D-aspartate receptors via Src kinase

  2013cites this paper
• Attenuation of methamphetamine seeking by the mGluR2/3 agonist LY379268 in rats with histories of restricted and escalated self-administration.

  2013cites this paper
• A compendium of cyclic sugar amino acids and their carbocyclic and heterocyclic nitrogen analogues

  2013cites this paper
• The metabotropic glutamate 2/3 receptor agonist LY379268 induces anxiety-like behavior at the highest dose tested in two rat models of anxiety.

  2013cites this paper
• Effects of metabotropic glutamate receptor ligands on male sexual behavior in rats.

  2013cites this paper
• Effects of group II and III metabotropic glutamate receptor ligands on conditioned taste aversion learning.

  2013cites this paper
• Metabotropic glutamate receptors as targets for antiepileptic drug therapy: A behavioral and electroencephalographic analysis

  2013cites this paper
• Group II Metabotropic Glutamate Receptor Agonist LY379268 Regulates AMPA Receptor Trafficking in Prefrontal Cortical Neurons

  2013cites this paper
• The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6/2 Huntington's disease mice.

  2012cites this paper
• Interactions of neurotransmitter systems during postnatal development of the rat hippocampal formation: effects of cisplatin.

  2012cites this paper
• Glutamate Receptor Abnormalities in Schizophrenia: Implications for Innovative Treatments

  2012cites this paper
• (–)‐2‐oxa‐4‐aminobicylco[3.1.0]hexane‐4,6‐dicarboxylic acid (LY379268) and 3‐[(2‐methyl‐1,3‐thiazol‐4‐yl)ethynyl]piperidine (MTEP) similarly attenuate stress‐induced reinstatement of cocaine seeking

  2012cites this paper
• Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia.

  2012cites this paper
• The role of glutamate signaling in pain processes and its regulation by GCP II inhibition.

  2012cites this paper
• On the mechanism of anti-hyperthermic effects of LY379268 and LY487379, group II mGlu receptors activators, in the stress-induced hyperthermia in singly housed mice.

  2012cites this paper
• Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power.

  2012cites this paper
• Attention deficit induced by blockade of N-methyl D-aspartate receptors in the prefrontal cortex is associated with enhanced glutamate release and cAMP response element binding protein phosphorylation: role of metabotropic glutamate receptors 2/3.

  2011cites this paper
• Progress in the developement of positive allosteric modulators of the metabotropic glutamate receptor 2.

  2011cites this paper
• Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice.

  2011cites this paper
• The Metabotropic Glutamate 2/3 Receptor Agonist LY379268 Blocked Nicotine-Induced Increases in Nucleus Accumbens Shell Dopamine only in the Presence of a Nicotine-Associated Context in Rats

  2011cites this paper
• Classical neurotransmitters and neuropeptides involved in generalized epilepsy: a focus on antiepileptic drugs.

  2011cites this paper
• Glutamatergic neuroplasticity in cocaine addiction.

  2011cites this paper
• Activation of Group II Metabotropic Glutamate Receptors Inhibits the Discriminative Stimulus Effects of Alcohol via Selective Activity Within the Amygdala

  2011cites this paper
• Enhancement of CA3 hippocampal network activity by activation of group II metabotropic glutamate receptors

  2011cites this paper
• Metabotropic glutamate receptor blockade in nucleus accumbens shell shifts affective valence towards fear and disgust

  2011cites this paper
• Role of the Transcription Factor CREB in the NMDA Receptor Antagonist-Induced Attention Deficits

  2011cites this paper
• Diastereoselectivity control in formal nucleophilic substitution of bromocyclopropanes with oxygen- and sulfur-based nucleophiles.

  2011cites this paper
• Enhancement of CA 3 hippocampal network activity by activation of group II metabotropic glutamate receptors

  2011cites this paper
• Awake Rat Pharmacological Magnetic Resonance Imaging as a Translational Pharmacodynamic Biomarker: Metabotropic Glutamate 2/3 Agonist Modulation of Ketamine-Induced Blood Oxygenation Level Dependence Signals

  2011influential citation
• Methodology for rapid measures of glutamate release in rat brain slices using ceramic-based microelectrode arrays: basic characterization and drug pharmacology.

  2011cites this paper
• Activation of metabotropic glutamate 2/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmission

  2011cites this paper
• Group II Metabotropic Glutamate Receptor Agonist Ameliorates MK801-Induced Dysfunction of NMDA Receptors via the Akt/GSK-3β Pathway in Adult Rat Prefrontal Cortex

  2011cites this paper
• Papel del glutamato en la regulación de la conducta agresiva en modelos animales

  2010cites this paper
• Oral administration of the NAALADase inhibitor GPI-5693 attenuates cocaine-induced reinstatement of drug-seeking behavior in rats.

  2010cites this paper
• Inhibition of NAALADase by 2‐PMPA attenuates cocaine‐induced relapse in rats: a NAAG‐mGluR2/3‐mediated mechanism

  2010cites this paper
• mGLU3 metabotropic glutamate receptors modulate the differentiation of SVZ‐derived neural stem cells towards the astrocytic lineage

  2010cites this paper
• Metabotropic glutamate receptor 3 activation prevents nitric oxide‐induced death in cultured rat astrocytes

  2010cites this paper
• Transcriptional regulation of type-2 metabotropic glutamate receptors: an epigenetic path to novel treatments for chronic pain.

  2010cites this paper
• Effects of a Positive Allosteric Modulator of Group II Metabotropic Glutamate Receptors, LY487379, on Cognitive Flexibility and Impulsive-Like Responding in Rats

  2010influential citation
• Cocaine‐induced neuroadaptations in glutamate transmission

  2010cites this paper
• Cerebrovascular Accidents in Elderly People Treated with Antipsychotic Drugs

  2010cites this paper
• The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat

  2010influential citation
• Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss.

  2010cites this paper
• The mGluR2/3 Agonist LY379268 Blocks the Effects of GLT-1 Upregulation on Prepulse Inhibition of the Startle Reflex in Adult Rats

  2010influential citation
• New Pharmacological Approaches to the Treatment of Schizophrenia

  2009cites this paper
• [New pharmacological approaches to the treatment of schizophrenia].

  2009influential citation